Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2005-12-22
2010-06-22
Helms, Larry R. (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S391100, C530S391300, C530S391700, C436S547000, C436S512000, C424S130100
Reexamination Certificate
active
07741443
ABSTRACT:
The present invention provides a human C-type lectin, binding molecules that specifically bind to the human C-type lectin, nucleic acid molecules encoding the binding molecules or the human C-type lectin, compositions comprising the binding molecules or the human C-type lectin and methods of identifying or producing the binding molecules. The human C-type lectin is specifically expressed on myeloid cells and binding molecules capable of specifically binding to the human C-type lectin can be used in the diagnosis, prevention and/or treatment of neoplastic disorders and diseases.
REFERENCES:
patent: 4885172 (1989-12-01), Bally et al.
patent: 5059421 (1991-10-01), Loughrey et al.
patent: 5171578 (1992-12-01), Bally et al.
patent: 5316771 (1994-05-01), Barenholz et al.
patent: 5380531 (1995-01-01), Chakrabarti et al.
patent: 5945589 (1999-08-01), Rao et al.
patent: 6265150 (2001-07-01), Terstappen et al.
patent: 6534631 (2003-03-01), Ruben et al.
patent: 6627195 (2003-09-01), Paul
patent: 6953843 (2005-10-01), Bakker et al.
patent: 7319140 (2008-01-01), Bakker et al.
patent: 2002/0022031 (2002-02-01), Goldenberg et al.
patent: 2006/0247420 (2006-11-01), Coukos et al.
patent: WO 98/15833 (1998-04-01), None
patent: WO 00/63403 (2000-10-01), None
patent: WO0157188 (2001-09-01), None
patent: WO 01/73133 (2001-10-01), None
patent: WO 02/103012 (2002-12-01), None
patent: WO 03/042367 (2003-05-01), None
patent: WO2004067569 (2004-08-01), None
patent: WO 2005/000894 (2005-01-01), None
Paul, Fundamental Immunology, 3rd Edition, 1993, pp. 292-295.
Rudikoff et al., Proc. Natl. Acad. Sci. USA 1982 vol. 79: p. 1979.
Casset et al. BBRC 307, 198-205 2003.
Pascalis et al., The Journal of Immunology vol. 169, 3076-3084, 2002.
Sequence search result -1.
Sequence search result -2.
Sequence search result -3.
Rudikoff et al., Proc. Natl. Acad. Sci. USA 1982, vol. 79: p. 1979.
Sequence search result for SEQ ID No.13 (2009).
PCT International Search Report. PCT/EP2004/051243, dated May 2, 2005.
PCT International Preliminary Examination Report, PCT/EP2004/051243, dated Sep. 29, 2005.
Barten et at, The human Ly-49L gene, Immunogenetics, 1990, pp. 731-734, vol. 49 and database EMBL XP002305617.
Database EMBL Mar. 26, 2001, WP002305618 retrieved from EBI, Database accession No. AF247788, abstract.
Database WPI Week 200229, Derwent Publications Ltd., London, GB; XP-002305620, Dec. 12, 2001, abstract.
Marshall et al., Identification and characterization of a novel human myeloid inhibitory C-type lectin-like receptor (MICL) that is predominantly expressed on granulocytes and Monocytes, The Journal of Biological Chemistry, Apr. 9, 2004, pp. 14792-14802, vol. 279, No. 15 and database EMBL Feb. 2, 2004, XP002305619.
Moretta et al., Human NK-cell receptors, Immunology Today, Sep. 1, 2001, pp. 420-422, vol. 21, No. 9, Elsevier Publications, Cambridge, GB.
Hofer et al., The centromeric part of the human natural killer (NK) receptor complex: lectin-like receptor genes expressed in Nk, dendritic and endothelial cells, Immunological reviews, Jun. 2001, pp. 5.19, vol. 181.
Han et al., KLRL1, A novel killer cell lectinlike receptor, inhibits natural killer cell cytotoxicity, Blood, Nov. 1, 2004, pp. 2858-2866, vol. 104, No. 9.
Bakker Adrianus Q.
Bakker Alexander Berthold Hendrik
van den Oudenrijn Sonja
van Meijer Marja
Crucell Holland B.V.
Helms Larry R.
TraskBritt
Yao Lei
LandOfFree
Binding molecules for the treatment of myeloid cell... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Binding molecules for the treatment of myeloid cell..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Binding molecules for the treatment of myeloid cell... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4243681